Form: 8-K

Current report filing

June 17, 2014

FineTech
JUNE 12, 2014
Exhibit 99.3
Welcome to FineTech Pharmaceutical


FineTech
JUNE 12, 2014
•
Manufactures high value, low volume specialty APIs and provides
organic synthesis capabilities for OPKO's drug development projects
•
Operates in a 35,000 sq. ft. sate of the art, FDA approved facility
with top of the line equipment
•
Employs a highly motivated, experienced and creative team of 40
employees, mostly with Ph.D. or M.Sc. degrees
•
Customers include leading generic pharmaceutical companies in the
USA, Canada, Europe, Israel and South America
•
Cost-efficient business with rapidly growing sales and very high
margins


FineTech
JUNE 12, 2014
What is the SECRET of this exceptionally high profitability?
QUESTION:


FineTech
JUNE 12, 2014
•
Facility/Equipment
•
Science/Technology
•
Ability to Create Intellectual Property
•
Regulatory Affairs
•
Effective Management of a Creative Team
•
Commercial Acumen in choosing the right product at the right time
ANSWER:
PERFECT QUALITY MIX


FineTech
JUNE 12, 2014
This PERFECT QUALITY MIX enables a customer to
be the first generic company to launch a specialty
product with complex chemistry or patent
challenges.  In such cases companies are prepared
to pay substantial premiums and commit to long-
term agreements.


FineTech
JUNE 12, 2014
Cabergoline
Latanoprost
Nabilone
Travoprost
Bimatoprost


FineTech
JUNE 12, 2014
SR-3306 –  treatment of  Parkinson disease
C-34 – anti-tumor and immune-stimulating activity
Disaccharides – treatment of asthma
Different derivatives of vitamin D and CYP -24
inhibitors


FineTech
JUNE 12, 2014


FineTech
JUNE 12, 2014


FineTech
JUNE 12, 2014


FineTech
JUNE 12, 2014